InsidersTradesSigma
Browse the complete record of transactions filed by Apelian David, Director. Officer active across 1 companies, notably Eiger BioPharmaceuticals, Inc.. Cumulatively, 1 disclosures have been logged. The latest transaction was disclosed on 11 March 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
David Apelian serves as a Board Member at Eiger BioPharmaceuticals, Inc. In this role, he contributes to the strategic direction of the company, which focuses on developing treatments for rare diseases. His experience in the biopharmaceutical sector allows him to provide valuable expertise to the board.